| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |